DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde


Loibl S, von Minckwitz G, Schneeweiss A et al.
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer.

J Clin Oncol 2014;
32: 3212-3220

Download Bibliographical Data

Search in: